Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Torasemide 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Torsemide 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Torsemide 20mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Torsemide 50mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Torsemide 10mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing torasemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 2.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Torasemide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Torasemide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing torasemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torsemide 10mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Torsemide 20mg/2mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Torasemide adverse reaction |
Causative agent (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to torasemide |
Causative agent (attribute) |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to torasemide |
Causative agent (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 2.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 2.5mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torsemide 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torsemide 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 2.5mg tablet (substance) |
Has precise active ingredient |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 5 mg oral tablet |
Has precise active ingredient |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 10 mg oral tablet |
Has precise active ingredient |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide 20 mg oral tablet |
Has precise active ingredient |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torsemide 100 mg oral tablet |
Has precise active ingredient |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Torasemide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only torasemide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only torasemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely spironolactone 50 milligram and torasemide 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely spironolactone 50 milligram and torasemide 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing spironolactone and torasemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only spironolactone and torasemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing spironolactone and torasemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only spironolactone and torasemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Torasemide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |